FdaApplication
NDA 205626
Identifiers
- fda_app_no: NDA205626
Properties
| Property | Value |
|---|---|
| applicant_name | MICRO LABS LTD |
| application_type | NDA |
| approval_date | 2018-08-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE | LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE | 150MG;200MG;300MG | TABLET;ORAL |
1 product